Veterinary Cardiology Market Size, Share & Trends Analysis Report By Animal Type (Companion, Production), By Product (Pharmaceuticals, Diagnostics), By Indication, By End Use, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
Veterinary Cardiology Market Size & Trends
The globalveterinary cardiology market size was estimated at USD 2.64 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030. The increasing demand forpet humanization and rising pet ownership globally has increased the demand for veterinary cardiology. Pet owners treat their pets as family members and aim to provide them with the utmost care and comfort. This includes the provision of regular healthcare services. According to the Global State of Pet Care statistics published by HealthforAnimals in September 2022, more than 50% of the world population is estimated to own a pet at home, and the pet population around the globe can amount to over a billion. The statistics further suggest that the rise of the middle class and changing family structure will likely contribute to the growing pet population.
Moreover, the increasing awareness regarding preventive health has led pet owners to spend more on their health to improve their overall well-being. According to an article published by the American Veterinary Medical Association in October 2022, the annual expenditure on veterinary visits for households owing a dog has increased to USD 362 in 2022 from USD 224 in 2020. In addition, the emphasis on preventive healthcare has encouraged pet owners to opt for pet insurance to provide their pets with better medical services. According to an article published by the Times of India in July 2022, the increasing pet adoption and maintenance in India is expected to increase pet insurance's growth by 14%. The rise in pet insurance is further expected to drive the market growth.
The market's growth can be primarily attributed to the rising prevalence of disorders in animals, increasing emphasis on animal health, and the growing popularity of pet insurance worldwide. These factors are significantly driving the escalating demand for veterinary cardiology services. For instance, according to the HealthforAnimals statistics for 2022, the increasing emphasis on monitoring companion animals and enhancing their well-being is fueling the growing demand for monitoring equipment, leading to a projected global expenditure of 4.6 billion on companion animal diagnostics in 2022.
In addition, the rising cardiac diseases in animals, primarily dogs and cats, are boosting the demand for veterinary cardiology across the globe. The Commonly Diagnosed Heart Disorders in Cats & Dogs are as follows:
- Congenital Heart Disease (CHD)
- Valvular Degeneration
- Hypertrophic Cardiomyopathy
- Heart Arrhythmias
- Dilated Cardiomyopathy
For instance, in June 2024, the Indian Council for Agricultural published a study highlighting the incidence of cardiac arrhythmias in 435 dogs with a history of generalized diseases over one year and two months from July 2022 to September 2023. The assessment was aimed to determine the occurrence of arrhythmias and found that 114 dogs (26.21%) displayed various types, including atrial fibrillation (30.70%), ST-segment coving, sinus arrest (9.65% each), and ST-segment elevation (8.77% each). Moreover, a rising prevalence of CHD among cattle is further driving the market growth. For instance, according to the Large Animal Review (LAR) study published in June 2023, CHD is a heart condition present at birth, with a reported prevalence ranging from 0.2% to 2.7% in cattle.
Global Veterinary Cardiology Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global veterinary cardiology market report based on animal type, product, indication, end use, distribution channel, and region.
- Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
- Companion Animals
- Dogs
- Cats
- Horses
- Others
- Production Animals
- Cattle
- Poultry
- Others
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceuticals
- Pimobendan
- Spironolactone and benazepril hydrochloride
- Others
- Diagnostics
- Physical exam
- Chest X-rays
- Electrocardiogram (ECG)
- Others
- Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Congestive Heart Failure
- Myocardial (Heart Muscle) Disease
- Arrhythmias
- Others
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Veterinary Hospitals & Clinics
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital/ Clinic Pharmacy
- Retail
- E-Commerce
- Region Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Sweden
- Denmark
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.